Glaucoma
📧 Sign up to get email alerts when something new happens for Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-01-03Clinical Trial Update: Macular Pigment and Visual Performance in Glaucoma Patients [Phase 1, Phase 2]
Phase 1/2 trial in glaucoma investigating macular pigment and visual performance has been terminated with results posted.
-
FDA approval · 2022-12-21FDA Approved: BRIMONIDINE TARTRATE — Original Application (Apotex Corp.)
FDA approved the original application for Brimonidine Tartrate by Apotex Corp., adding a generic option for treating glaucoma and ocular hyp…
-
FDA approval · 2022-12-20FDA Approved: BIMATOPROST — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA has approved a supplemental application for BIMATOPROST from Alembic Pharmaceuticals Inc., representing a supplemental approval for the …
-
FDA approval · 2022-12-19FDA Approved: LATANOPROST — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for latanoprost filed by Mylan Pharmaceuticals Inc.
-
FDA approval · 2022-12-12FDA Approved: BRIMONIDINE TARTRATE AND TIMOLOL MALEATE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approves Upsher-Smith's original application for a generic fixed-dose combination of brimonidine tartrate and timolol maleate ophthalmic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-12-05Clinical Trial Update: Early Feasibility Study of the Brown Glaucoma Implant in Patients With Severe Visual Impairment or No Light Perceived [NA]
Early feasibility study of the Brown Glaucoma Implant in patients with severe visual impairment or no light perception has completed; result…
-
FDA approval · 2022-11-28FDA Approved: LATANOPROST — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for latanoprost from Rising Pharma Holdings, Inc.
-
FDA approval · 2022-11-22FDA Approved: TIMOLOL MALEATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for timolol maleate submitted by Sandoz Inc. This action supplements an existing approval for the op…
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: Steroids and/ or Non-steroidal Anti-inflammatory Drugs in the Postoperative Regime After Trabeculectomy. [Phase 4]
Phase 4 trial update evaluating steroids and non-steroidal anti-inflammatory drugs in the postoperative regime after trabeculectomy for glau…
-
CLINICAL_TRIALS trial_result · 2022-10-19Clinical Trial Update: Primary Tube Versus Trabeculectomy Study [Phase 4]
Phase 4 trial comparing primary tube placement versus trabeculectomy for glaucoma has completed with results posted.
-
FDA approval · 2022-10-18FDA Approved: METHAZOLAMIDE — Original Application (Precision Dose, Inc.)
FDA approved Precision Dose, Inc.'s original application for methazolamide, a carbonic anhydrase inhibitor, as a new generic product for gla…
-
FDA approval · 2022-10-06FDA Approved: BIMATOPROST — Original Application (Aurobindo Pharma Limited)
The FDA approved the Original Application for BIMATOPROST (bimatoprost) by Aurobindo Pharma Limited under ANDA205537.
-
CLINICAL_TRIALS withdrawal · 2022-10-04Clinical Trial Update: Augmented Macular Pigment-containing Nutraceutical and Central Visual Function [Phase 4]
Phase 4 trial investigating augmented macular pigment nutraceutical for glaucoma has been withdrawn.
-
FDA approval · 2022-10-04FDA Approved: BRIMONIDINE TARTRATE AND TIMOLOL MALEATE — Original Application (Florida Pharmaceutical Products, LLC)
FDA approved a generic combination product of brimonidine tartrate and timolol maleate for lowering intraocular pressure in glaucoma or ocul…
-
CLINICAL_TRIALS trial_result · 2022-09-23Clinical Trial Update: Study Comparing the P200TE and the P200TxE in Glaucoma Patients [NA]
A completed clinical trial comparing two devices (P200TE and P200TxE) in glaucoma patients with results posted in 2022.
-
FDA approval · 2022-09-22FDA Approved: OMLONTI — Original Application (Ocuvex Therapeutics, Inc.)
The FDA approved OMLONTI (omidenepag isopropyl) from Ocuvex Therapeutics as an Original Application (NDA 215092) for reducing intraocular pr…
-
FDA approval · 2022-09-22FDA Approved: TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION 0.25% — Original Application (NorthStar RxLLC)
The FDA approved NorthStar RxLLC's timolol maleate ophthalmic gel forming solution 0.25% under an Original Application (ANDA) for open-angle…
-
FDA approval · 2022-07-26FDA Approved: ACETAZOLAMIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for acetazolamide filed by Strides Pharma Science Limited, authorizing an update to the generic prod…
-
CLINICAL_TRIALS trial_result · 2022-07-21Clinical Trial Update: XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma: Gold-Standard Pathway Study (GPS) [Phase 4]
Phase 4 trial update comparing XEN-45 Gel Stent to trabeculectomy in glaucoma; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: 5 Years Long Term Results After Standalone CyPass-Implantation
Five-year long-term results update from a standalone CyPass implantation trial for glaucoma.
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: visuALL Field Analyzer (vFA) Compared to Standard Humphrey Automated Perimetry [NA]
Clinical trial update comparing visuALL Field Analyzer to standard Humphrey automated perimetry in glaucoma subjects has completed with resu…
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: A Prospective, Multicenter Study of the OMNI® Surgical System in Pseudophakic Eyes With Open Angle Glaucoma [NA]
A multicenter prospective trial of the OMNI Surgical System in pseudophakic eyes with open-angle glaucoma was terminated; results were poste…
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Outcomes Mandate National Integration With Cannabis as Medicine [Phase 2]
Phase 2 clinical trial update focusing on integrating cannabis as medicine for various chronic pain conditions, with status currently UNKNOW…
-
CLINICAL_TRIALS trial_result · 2022-05-31Clinical Trial Update: Ahmed Glaucoma Valve Surgery With Mitomycin-C [Phase 2]
Phase 2 trial update for Ahmed Glaucoma Valve surgery with Mitomycin-C in glaucoma patients; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: Prospective, Double-masked, Randomized, Multi-center, Active-controlled, Parallel-group, 3-month Study Assessing the Safety & Ocular Hypotensive Efficacy of TC-002 Ophthalmic Solution Compared to Latanoprost Ophthalmic Solution 0.005% in Subjects With Elevated Intraocular Pressure [Phase 3]
Phase 3 trial comparing TC-002 ophthalmic solution to latanoprost for safety and ocular pressure reduction in elevated intraocular pressure;…